Acute treatment of pediatric headache in the emergency department and inpatient settings.
Migraine headache can be debilitating. If initiated early, aggressive management may prevent severe disability and failure at school. It must be noted that treatments available for use for acute migraine headache in children and adolescents are off-label. Their use is widespread, but double-blind, placebo-controlled studies are still unavailable for this age group.
Kabbouche
Marielle A
MA
Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA. marielle.kabbouche@cchmc.org
Linder
Steven L
SL
D000208:Acute Disease; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004636:Emergency Service, Hospital; D006261:Headache / Q000188:drug therapy*; D006760:Hospitalization; D006801:Humans; D008787:Metoclopramide / Q000008:administration & dosage; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D018170:Sumatriptan / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D017366:Serotonin Receptor Agonists; D004087:Dihydroergotamine; D018170:Sumatriptan; D008787:Metoclopramide